The Experience of Screening for SCID

This project will evaluate the impact of including Severe Combined Immunodeficiency into the newborn bloodspot screening panel. It will recruit parents and health professionals primarily from the sites where this new form of screening is being trialled well as additional sites where clinicians will be involved in the care of these babies and comparator groups are needed. The proposed work will consist of two work packages. The first, a mixed-methods study conducted with families from the point of screening information being returned through to the child's fifth birthday. The second, a qualitative interview study conducted with health professionals during the clinical evaluation phase of the national pilot programme.

NCT Number	NCT05651113
Lead Sponsor	King's College London Collaborators: University of Manchester, University of Sheffield, Coventry University, National Health Service, United Kingdom
Conditions	Severe Combined Immunodeficiency
Enrollment	90 participants
Start Date	2022-11-09
Primary Completion	2029-03-31 (estimated)
Study Completion	2029-03-31 (estimated)
Updated on ClinicalTrials.gov	2022-12-14